Cognitive testing for stress-induced exhaustion and depression
Official title: PrimeCog: Cognitive Profile, Psychosocial Characteristics, Brain MRI and Biomarkers for Stress and Neurodegeneration in Patients With Depression or Stress Induced Exhaustion Disorder in Primary Care.
Run by Region Östergötland · NCT06346535 · Data updated 2026-11-12
This study is trying to see if different tests can help tell apart stress-induced exhaustion and depression in adults aged 18 to 65, to improve how we diagnose and treat these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Region Östergötland Academic / other |
| Locations | 1 site (Linköping, Östergötland County) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | April 1, 2027 |
| Study ends | April 1, 2029 |
| Registry record updated | April 23, 2024 |
| Trial ID | NCT06346535 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 65 who are newly diagnosed with MDD or SED and fluent in Swedish.
✕Probably not a fit
Patients with a history of serious mental illness, ongoing treatment for MDD/SED, or contraindications to MRI may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The PrimeCog project aims to differentiate between stress-induced exhaustion disorder (SED) and major depressive disorder (MDD) by analyzing symptomatology and pathophysiology in comparison to healthy controls. Participants, aged 18 to 65, will be recruited from primary care centers and will undergo a series of assessments including digital cognitive tests, blood, saliva, and hair sample collection, as well as MRI scans of the brain. This multicenter longitudinal study will track changes over 12 and 24 months to identify biomarkers and cognitive differences among the groups. The goal is to develop new diagnostic tools that can guide individualized treatment strategies based on cognitive function and underlying biological mechanisms.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic tools and personalized treatment strategies for patients with MDD and SED.
How similar studies have gone: While the approach of using cognitive testing and biomarkers is promising, the specific methodology of this study appears to be novel and untested in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. adults 18 to 65 years old; 2. fluent in Swedish; 3. corrected to normal vision and hearing; 4. (for cases), newly diagnosed with MDD or SED (i.e., received as new diagnosis at the visit to the physician) according to the diagnostic criteria from DSM-V (MDD) and the Swedish Board of Health and Welfare (SED) Exclusion Criteria: 1. already ongoing treatment for MDD/SED or previous diagnosis of MDD/SED within the last year; 2. history of serious mental illness (defined as mental illness that has required psychiatric in-patient care); 3. acute cerebrovascular event or severe head trauma in the last 6 months; 4. known cognitive impairment; 5. substance dependence, ongoing or past; 6. motor disability or impairment affecting interaction with the digital tests; 7. photosensitive epilepsy or -migraines. For the MRI subgroup, any contraindication to MRI is an exclusion criterion.
Where it's running
-
Region Ostergotland, primary care centrum
Linköping, Östergötland County, Sweden Recruiting
Study contacts
- Principal investigator: Hanna Israelsson Larsen, PhD — Region Ostergotland/Linkoping University
- Study coordinator: Hanna Israelssion Larsen, PhD
- Email: hanna.israelsson.larsen@regionostergotland.se
- Phone: +46738317008
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual Reality Program to Support Healthcare Workers
A brief immersive virtual reality program is being tested to see if it helps reduce burnout and improve well-being for healthcare workers.
-
Online Training for Primary Health Care Workers on Physical Activity and Sedentary Behavior Counseling
A online training program is being tested to help primary health care professionals better counsel patients about physical activity and reducing sitting time.
-
Baricitinib for Depression and Cognition in Experienced Male Football Players
In this Phase 2 study, adult male football players with depression and inflammation will try baricitinib to see if reducing inflammation helps their depressive and cognitive symptoms.
-
Generative AI pre-visit care tool for Fitbit users
This test tries generative AI that helps adult Fitbit users understand symptoms and prepare information to bring to a health visit.
-
REACH-OUT: A technology-based approach to improve blood pressure in reproductive-age women at community clinics
This trial tests a technology-enabled strategy to help young women with hypertension manage their BP and adhere to blood pressure medications in Federally Qualified Health Centers.
-
Intensive case management linking VA and community care to prevent suicide in Veterans
This trial will test whether SUPERCEDE, an intensive case-management program that links VA and VA-authorized community care, helps Veterans at risk for suicide get faster, better-coordinated mental health care than present-centered therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.